Positive Topline Results for New Cervical Dystonia Treatment Positive Topline Results for New Cervical Dystonia Treatment

DaxibotulinumtoxinA for treatment of cervical dystonia met the primary and secondary endpoints in the ASPEN-1 phase 3 trial, Revance Therapeutics reports.Medscape Medical News
Source: Medscape Neurology and Neurosurgery Headlines - Category: Neurology Tags: Neurology & Neurosurgery News Source Type: news